N-(4-((6-Methoxy-7-(3-Morpholinopropoxy)quinazolin-4-yl)aMino)phenyl)benzaMide
98%
- Product Code: 72790
CAS:
331771-20-1
| Molecular Weight: | 513.6 g./mol | Molecular Formula: | C₂₉H₃₁N₅O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08703125 | |
| Melting Point: | 117-120°C | Boiling Point: | 639.671°C |
| Density: | 1.282 g/cm3 | Storage Condition: | -20°C |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted cancer therapies. It functions as an inhibitor of specific tyrosine kinases, which are enzymes that play a critical role in the signaling pathways that regulate cell growth and proliferation. By inhibiting these kinases, the compound helps to halt the uncontrolled growth of cancer cells, making it a promising candidate for the treatment of various types of cancers, including lung, breast, and colorectal cancers. Additionally, its unique structure allows for enhanced selectivity and potency, reducing the likelihood of off-target effects and improving therapeutic outcomes. Research is ongoing to further explore its efficacy and potential applications in combination with other anticancer agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿3,321.00 |
+
-
|
N-(4-((6-Methoxy-7-(3-Morpholinopropoxy)quinazolin-4-yl)aMino)phenyl)benzaMide
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of targeted cancer therapies. It functions as an inhibitor of specific tyrosine kinases, which are enzymes that play a critical role in the signaling pathways that regulate cell growth and proliferation. By inhibiting these kinases, the compound helps to halt the uncontrolled growth of cancer cells, making it a promising candidate for the treatment of various types of cancers, including lung, breast, and colorectal cancers. Additionally, its unique structure allows for enhanced selectivity and potency, reducing the likelihood of off-target effects and improving therapeutic outcomes. Research is ongoing to further explore its efficacy and potential applications in combination with other anticancer agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :